GlassScriptPhysician profile
Paul A Lenz
NPI 1669446175
$3,574.14
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $585 · 2020: $135 · 2021: $300 · 2022: $1,288 · 2023: $1,044 · 2024: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,250 · Education: $16.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,250.01 |
| Education | $16.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $807.09 | 2021-2023 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $369.91 | 2019-2024 | Farxiga, Breztri, Lynparza |
| Lilly USA, LLC | $213.38 | 2019-2024 | Mounjaro |
| Merck Sharp & Dohme LLC | $191.06 | 2020-2023 | Keytruda |
| Amarin Pharma, INC. | $186.17 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $173.38 | 2022 | |
| Glaxosmithkline, LLC. | $169.53 | 2022-2023 | Shingrix, Trelegy Ellipta, Arexvy |
| Janssen Pharmaceuticals, INC | $169.50 | 2022 | |
| Rigel Pharmaceuticals, INC. | $145.97 | 2022 | |
| Eisai INC. | $127.05 | 2023 | |
| Sumitomo Pharma America, INC. | $124.81 | 2023 | Orgovyx |
| E.R. Squibb & Sons, L.L.C. | $123.25 | 2023 | Opdivo |
| Amgen INC. | $109.73 | 2019-2023 | Otezla, Repatha |
| Mannkind Corporation | $106.98 | 2019 | |
| Genentech USA, INC. | $95.58 | 2019-2023 | Tecentriq |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $85.28 | 2022 | |
| Janssen Biotech, INC. | $83.66 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $82.05 | 2022-2024 | |
| Seagen INC. | $72.31 | 2022 | |
| Nestle Healthcare Nutrition INC. | $35.77 | 2023 | |
| Exact Sciences Corporation | $26.61 | 2023-2024 | Cologuard Collection Kit |
| Abbvie INC. | $23.99 | 2024 | |
| Pfizer INC. | $18.83 | 2024 | |
| Radius Health, INC. | $18.64 | 2019 | |
| Redhill Biopharma INC. | $13.61 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Lenz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.